Literature DB >> 29892471

Heart Failure in Sub-Saharan Africa.

Joseph Gallagher1, Kenneth McDonald2, Mark Ledwidge2, Chris J Watson3.   

Abstract

Heart failure is a growing problem in sub-Saharan Africa. This arises as the prevalence of risk factors for cardiovascular disease rises, life expectancy increases and causes of heart failure more common in Africa, such as rheumatic heart disease and endomyocardial fibrosis, continue to be a significant issue. Lack of access to diagnostics is an issue with the expense and technical expertise required for echocardiography limiting access. Biomarker strategies may play a role here. Access to essential medicines is also limited and requires a renewed focus by the international community to ensure that appropriate medications are readily available, similar to that which has been implemented for HIV and malaria.

Entities:  

Keywords:  Africa; Heart failure; echocardiography; essential medicines; natriuretic peptides

Year:  2018        PMID： 29892471      PMCID： PMC5971674          DOI： 10.15420/cfr.2018:4:1

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN： 2057-7540


  43 in total

1.  Classification of heart failure in population based research: an assessment of six heart failure scores.

Authors:  A Mosterd; J W Deckers; A W Hoes; A Nederpel; A Smeets; D T Linker; D E Grobbee
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

2.  Heart failure in sub-saharan Africa: time for action.

Authors:  Albertino Damasceno; Gad Cotter; Anastase Dzudie; Karen Sliwa; Bongani M Mayosi
Journal:  J Am Coll Cardiol       Date:  2007-10-23       Impact factor: 24.094

3.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2016-05-20       Impact factor: 15.534

4.  B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in Hypertension.

Authors:  Joe Gallagher; Chris Watson; Shuaiwei Zhou; Fiona Ryan; Mark Ledwidge; Kenneth McDonald
Journal:  Am J Hypertens       Date:  2018-01-12       Impact factor: 2.689

Review 5.  Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnostics.

Authors:  Nadezhda Glezeva; Joe Gallagher; Mark Ledwidge; John O'Donoghue; Kenneth McDonald; John Chipolombwe; Chris Watson
Journal:  Trop Med Int Health       Date:  2015-02-02       Impact factor: 2.622

Review 6.  State of the art: using natriuretic peptide levels in clinical practice.

Authors:  Alan Maisel; Christian Mueller; Kirkwood Adams; Stefan D Anker; Nadia Aspromonte; John G F Cleland; Alain Cohen-Solal; Ulf Dahlstrom; Anthony DeMaria; Salvatore Di Somma; Gerasimos S Filippatos; Gregg C Fonarow; Patrick Jourdain; Michel Komajda; Peter P Liu; Theresa McDonagh; Kenneth McDonald; Alexandre Mebazaa; Markku S Nieminen; W Frank Peacock; Marco Tubaro; Roberto Valle; Marc Vanderhyden; Clyde W Yancy; Faiez Zannad; Eugene Braunwald
Journal:  Eur J Heart Fail       Date:  2008-08-29       Impact factor: 15.534

Review 7.  Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa.

Authors:  Bongani M Mayosi
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

8.  A population study of endomyocardial fibrosis in a rural area of Mozambique.

Authors:  Ana Olga Mocumbi; Maria Beatriz Ferreira; Daniel Sidi; Magdi H Yacoub
Journal:  N Engl J Med       Date:  2008-07-03       Impact factor: 91.245

9.  Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.

Authors:  Rasha Khatib; Martin McKee; Harry Shannon; Clara Chow; Sumathy Rangarajan; Koon Teo; Li Wei; Prem Mony; Viswanathan Mohan; Rajeev Gupta; Rajesh Kumar; Krishnapillai Vijayakumar; Scott A Lear; Rafael Diaz; Alvaro Avezum; Patricio Lopez-Jaramillo; Fernando Lanas; Khalid Yusoff; Noorhassim Ismail; Khawar Kazmi; Omar Rahman; Annika Rosengren; Nahed Monsef; Roya Kelishadi; Annamarie Kruger; Thandi Puoane; Andrzej Szuba; Jephat Chifamba; Ahmet Temizhan; Gilles Dagenais; Amiram Gafni; Salim Yusuf
Journal:  Lancet       Date:  2015-10-20       Impact factor: 79.321

10.  A clinical study of pattern and factors affecting outcome in Nigerian patients with advanced heart failure.

Authors:  O B Familoni; T O Olunuga; B W Olufemi
Journal:  Cardiovasc J Afr       Date:  2007-10-22       Impact factor: 1.167
View more
  6 in total

Review 1.  Diagnosis and Management of Acute Heart Failure in Sub-Saharan Africa.

Authors:  Alice Kidder Bukhman; Vizir Jean Paul Nsengimana; Mindy C Lipsitz; Patricia C Henwood; Endale Tefera; Shada A Rouhani; Damas Dukundane; Gene Y Bukhman
Journal:  Curr Cardiol Rep       Date:  2019-08-31       Impact factor: 2.931

2.  Morin Augmented Myocardial eNOS/cGMP/PKG Signaling Pathway and Abated Oxidative and Inflammo-apoptotic Responses in Diethyl Phthalate and Bisphenol-S Co-Exposed Male Albino Rats.

Authors:  Adewale Segun James; Ofem Effiom Eteng; Oluwatosin Adebisi Dosumu; Ceasar Antiya Moses; Chukwuka Uzoamaka Ogbonna; Oladokun Abdulwasiu Adeleye; Emmanuel Ifeanyichukwu Ugwor; Blessing Chukwueku Omilo; Risikat Funmilayo Fabunmi; Aduragbemi Moses Olakitan; Regina Ngozi Ugbaja
Journal:  Inflammation       Date:  2022-07-28       Impact factor: 4.657

Review 3.  Endomyocardial Fibrosis: an Update After 70 Years.

Authors:  Ana Olga Mocumbi; J Russell Stothard; Paulo Correia-de-Sá; Magdi Yacoub
Journal:  Curr Cardiol Rep       Date:  2019-11-22       Impact factor: 2.931

4.  Trends in Annual Incidence Rates of Newly Diagnosed Endomyocardial Fibrosis Cases at the Uganda Heart Institute: A 14-Year Review.

Authors:  Twalib Olega Aliku; Joselyn Rwebembera; Sulaiman Lubega; Wanzhu Zhang; Charles Lugero; Judith Namuyonga; John O O Omagino; Emmy Okello; Peter Solomon Lwabi
Journal:  Front Cardiovasc Med       Date:  2022-04-15

5.  The prevalence, management, and thirty-day outcomes of symptomatic atrial fibrillation in a Tanzanian emergency department.

Authors:  Isaac O Oyediran; Sainikitha Prattipati; Francis M Sakita; Godfrey L Kweka; Tumsifu G Tarimo; Timothy Peterson; Zak Loring; Alexander T Limkakeng; Gerald S Bloomfield; Julian T Hertz
Journal:  Afr J Emerg Med       Date:  2021-10-14

6.  Spectrum of heart failure in sub-Saharan Africa: data from a tertiary hospital-based registry in the eastern center of Burkina Faso.

Authors:  Dakaboué Germain Mandi; Joel Bamouni; Rélwendé Aristide Yaméogo; Dangwé Temoua Naïbé; Elisé Kaboré; Yibar Kambiré; Koudougou Jonas Kologo; Georges Rosario Christian Millogo; Patrice Zabsonré
Journal:  Pan Afr Med J       Date:  2020-05-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.